Takeda Manufacturing Austria AG

WIEN, AustriaFEI 3002807133API manufacture registered

Takeda Manufacturing Austria AG is a drug establishment in WIEN, Austria, registered with the US FDA under FEI 3002807133. Its registered operations are: API manufacture. 9 EU/UK GMP certificates are matched to this site, 8 inspected within the last three years.

Sources: FDA Drug Establishments Current Registration Site (checked 2 Nov 2026); EudraGMDP; MHRA GMDP. Methodology

Registered operations

Business operations this establishment declares in its FDA registration. Registration is not an approval and says nothing about EU or UK GMP status.

API manufacture

GMP documents matched to this site (9)

DocumentAuthorityInspectionSource
483039-104783268
GMP certificate
Competent authority of Austria20 Mar 2026
within 3-year review window
EudraGMDP
483038-105130824
GMP certificate
Competent authority of Austria20 Mar 2026
within 3-year review window
EudraGMDP
483039-104916748
GMP certificate
Competent authority of Austria20 Mar 2026
within 3-year review window
EudraGMDP
483039-105522770
GMP certificate
Competent authority of Austria20 Mar 2026
within 3-year review window
EudraGMDP
483039-103639089
GMP certificate
Competent authority of Austria4 Jul 2025
within 3-year review window
EudraGMDP
483038-104067091
GMP certificate
Competent authority of Austria4 Jul 2025
within 3-year review window
EudraGMDP
483038-102665517
GMP certificate
Competent authority of Austria24 May 2024
within 3-year review window
EudraGMDP
483039-102665631
GMP certificate
Competent authority of Austria21 May 2024
within 3-year review window
EudraGMDP
483039-102632926
GMP certificate
Competent authority of Austria8 Mar 2022
outside 3-year review window
EudraGMDP

A GMP document is matched to this site when its address names the site's street and its city or postcode. In our latest internal review 59 of 60 sampled matches were the right site (not yet independently reviewed; measured match quality). Check the certificate's own address before relying on it. The three-year review window is the EMA guideline default after an inspection, not an official expiry date.

What this page does not show

  • Which substances are made here: DMFs and CEPs are filed by organisations, not sites, so we do not link substances to this site.
  • Capacity, scale, price or current availability: no regulator publishes these.
  • FDA inspection classifications for this site, which are not yet linked.

Other sites registered by the same company